Skip to Main Content
Back to News

Insider Sale: Chief Scientific Officer of $OCUL (OCUL) Sells 2,948 Shares

None

Jeffrey S. Heier, the Chief Scientific Officer of $OCUL ($OCUL), sold 2,948 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of their shares. Following this trade, they now own 269,059 shares of $OCUL stock.

$OCUL Insider Trading Activity

$OCUL insiders have traded $OCUL stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $OCUL stock by insiders over the last 6 months:

  • JEFFREY S. HEIER (Chief Scientific Officer) sold 2,948 shares.
  • PETER KAISER (Chief Development Officer) sold 2,897 shares.
  • SANJAY NAYAK (Chief Strategy Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 3,646 shares.
  • PRAVIN DUGEL (See Remarks) has traded it 2 times. They made 0 purchases and 2 sales, selling 41,560 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$OCUL Hedge Fund Activity

We have seen 75 institutional investors add shares of $OCUL stock to their portfolio, and 95 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles